Medline Inc. (MDLN) Stock Analysis
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $37.23, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%).
Medline is the largest provider of medical-surgical products and supply chain solutions, offering approximately 335,000 products across Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute settings. In 2025, 69% of... Read more
Hold if already holding. Not a fresh buy at $37.23, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%). Chart setup: No clear chart pattern; technical signals are mixed. Mixed signals. Hold existing position. Score 5.7/10, moderate confidence.
Passes 8/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Suitability: moderate.
Recent developments
updated 2026-06-15Recent Developments — Medline Inc.
Latest news
- NEWS Tigress Financial raises Medline stock price target on AI supply chain shift By Investing.com - Investing.com South Afri — Investing.com South Africa positive
- NEWS Tigress Financial raises Medline stock price target on AI supply chain shift - Investing.com Canada — Investing.com Canada positive
- NEWS Medline (NASDAQ:MDLN) Trading Down 10.5% - Here's Why - MarketBeat — MarketBeat negative
- NEWS Medline Stock Alert (MDLN) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of Medline Investo — ACCESS Newswire negative
- NEWS Medonde: Medline Stock (MDLN) Opinions on Q1 Earnings Release - Quiver Quantitative — Quiver Quantitative neutral
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerVizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs)69%10-K Item 1A: '69% of consolidated net sales ... under contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.'
- HIGHCustomerPrime Vendor agreements63%10-K Item 1A: 'Our active Prime Vendor agreements as of December 31, 2025 generated approximately 63.4% ($18.0 billion) of net sales'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $37.23, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%). Chart setup: No clear chart pattern; technical signals are mixed. Mixed signals. Hold existing position. Target $45.90 (+23.3%), stop $34.62 (−7.5%), A.R:R 2.0:1. Score 5.7/10, moderate confidence.
Take-profit target: $45.90 (+23.3% upside). Target $45.90 (+23.3%), stop $34.62 (−7.5%), A.R:R 2.0:1. Stop-loss: $34.62.
Concentration risk — Customer: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P. (GPOs) (69.0%); Concentration risk — Customer: Prime Vendor agreements (63.4%).
Medline Inc. trades at a P/E of 32.1 (forward 21.9). TrendMatrix value score: 6.7/10. Verdict: Hold.
35 analysts cover MDLN with a consensus score of 4.1/5. Average price target: $51.
What does Medline Inc. do?Medline is the largest provider of medical-surgical products and supply chain solutions, offering approximately 335,000...
Medline is the largest provider of medical-surgical products and supply chain solutions, offering approximately 335,000 products across Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute settings. In 2025, 69% of consolidated net sales came through member hospitals under GPO contracts with Vizient, HealthTrust, and Premier; Prime Vendor agreements generated 63.4% ($18.0B) of net sales.